(INVE-A) Investor ser. - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015811955
INVE-A: Private Equity, Healthcare, Financial Services, IT, Fintech
Investor AB Ser. A (ST:INVE-A) stands out as a seasoned player in the private equity landscape, with a strategic focus on mature, middle-market buyouts and growth investments. Their approach is rooted in a long-term perspective, which is a hallmark of their investment strategy.
Their sector focus is on healthcare, financial services, IT, and fintech—industries characterized by innovation and stability. This strategic selection allows them to capitalize on sectors with both growth potential and established market presence, ensuring a balanced portfolio.
Geographically, they maintain a strong presence in Northern Europe, while also exploring opportunities in regions like North Africa, Sub-Saharan Africa, and the Asia-Pacific. This diversity not only mitigates risk but also taps into emerging markets with promising growth trajectories.
Investment sizes range between SEK 20 million and SEK 200 million, indicating a targeted approach that balances substantial involvement with diversification. Their strategy involves both majority and minority stakes, reflecting their adaptability in different investment scenarios.
With a dual investment strategy, they actively engage in operating investments, seeking controlling interests and board positions to drive value. Conversely, their financial investments are more passive, focusing on shorter-term minority holdings, allowing for a flexible portfolio management approach.
Their exit strategy, envisioning a 3-7 year horizon, underscores their commitment to patient capital, aligning with the typical growth cycles of their portfolio companies. This timeframe allows for significant value creation before realizing returns.
Founded in 1916, Investor AB is headquartered in Stockholm, Sweden, boasting a market capitalization of 969.085 billion SEK. Their financial metrics, including a P/E ratio of 8.56, highlight their attractive valuation and potential for investor returns.
In summary, Investor AB Ser. A presents a compelling opportunity with its diversified strategy, sector expertise, and geographic reach, supported by a robust financial foundation and a proven track record in European markets.
Additional Sources for INVE-A Stock
INVE-A Stock Overview
Market Cap in USD | 93,588m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Environmental & Facilities Services |
IPO / Inception |
INVE-A Stock Ratings
Growth 5y | 90.1% |
Fundamental | 31.9% |
Dividend | 18.1% |
Rel. Strength | 3.59 |
Analysts | - |
Fair Price Momentum | 321.63 SEK |
Fair Price DCF | 311.38 SEK |
INVE-A Dividends
Dividend Yield 12m | 1.62% |
Yield on Cost 5y | 5.25% |
Annual Growth 5y | -21.64% |
Payout Consistency | 90.3% |
INVE-A Growth Ratios
Growth Correlation 3m | 5.1% |
Growth Correlation 12m | 82.5% |
Growth Correlation 5y | 91.2% |
CAGR 5y | 26.21% |
CAGR/Max DD 5y | 0.90 |
Sharpe Ratio 12m | 1.19 |
Alpha | 3.76 |
Beta | 0.755 |
Volatility | 21.18% |
Current Volume | 409.2k |
Average Volume 20d | 323.1k |
As of April 04, 2025, the stock is trading at SEK 293.80 with a total of 409,174 shares traded.
Over the past week, the price has changed by -4.80%, over one month by -9.21%, over three months by -0.94% and over the past year by +12.43%.
Neither. Based on ValueRay Fundamental Analyses, Investor ser. is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.90 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INVE-A as of April 2025 is 321.63. This means that INVE-A is currently overvalued and has a potential downside of 9.47%.
Investor ser. has no consensus analysts rating.
According to ValueRays Forecast Model, INVE-A Investor ser. will be worth about 359.7 in April 2026. The stock is currently trading at 293.80. This means that the stock has a potential upside of +22.42%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 315 | 7.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 359.7 | 22.4% |